1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. BEAM THERAPEUTICS INC
Beam Therapeutics Inc XNAS: BEAM
20.15 0.22 (1.10%)
2.8M
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Beam Therapeutics Inc is on 06 Aug 2025 for the purpose of Beam Therapeutics Inc Second Quarter Earnings Results for 2025 See details

Beam Therapeutics Inc - BEAM - stock price prediction, stock price target, analyst ratings from 17 analysts

Beam Therapeutics Inc has a share price target of US$ 44, revenue growth forecast of -12.8%, and profit growth estimate of -12.3% for FY25, based on top 17 analyst calls.